As the condition progresses to high-grade PanINs, tumor suppressor genes become inactivated, including the dysregulation of CDKN2A and the loss of TP53 and SMAD4 [261] These findings establish definitive molecular signatures of invasive malignancy (Fig. 6). This evidence concerns the gene CDKN2A and neoplasm.